1370007-54-7

Basic information

• Product Name: 7-Bromo-4-(Methylthio)Pyrrolo[2,1-F][1,2,4]Triazine
• Synonyms: 7-Bromo-4-(Methylthio)Pyrrolo[2,1-F][1,2,4]Triazine;7-Bromo-4-(Methylthio)Pyrrolo[2,1-F][1,2,4]Triazine(WXC00622)
• CAS NO: 1370007-54-7
• Molecular Formula: C₇H₆BrN₃S
• Molecular Weight: 244.11164
• Mol File: 1370007-54-7.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Density: 1.81±0.1 g/cm3(Predicted)
• PKA: -1.91±0.30(Predicted)
• CAS DataBase Reference: 7-Bromo-4-(Methylthio)Pyrrolo[2,1-F][1,2,4]Triazine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Bromo-4-(Methylthio)Pyrrolo[2,1-F][1,2,4]Triazine(1370007-54-7)
• EPA Substance Registry System: 7-Bromo-4-(Methylthio)Pyrrolo[2,1-F][1,2,4]Triazine(1370007-54-7)

Safety Data

• Hazardous Substances Data: 1370007-54-7(Hazardous Substances Data)

Upstream product

• 2199-43-1 ethyl 1H-pyrrole-2-carboxylate 
• 159326-71-3 pyrrolo[1,2-f][1,2,4]triazin-4-ol 
• 628733-99-3 ethyl 1-amino-1H-pyrrole-2-carboxylate 
• 1370007-53-6 7-bromopyrrolo[2,1-f][1,2,4]triazin-4-ol 
• 1269667-51-7 7-bromo-4-chloropyrrolo[2,1-f][1,2,4]triazine 
• 5188-07-8 sodium thiomethoxide 

Downstream Products

• 1392515-06-8 (1R,4S)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopent-2-en-1-ol 
• 1370007-76-3 C₂₀H₂₁N₃O₄S 
• 1370007-78-5 [(1S,4S)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopent-2-en-1-yl] benzoate 
• 1370007-80-9 [(1S,2R,4R)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopentyl] benzoate 
• 1370007-82-1 [(1S,2S,4R)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopentyl] benzoate 
• 1370007-75-2 (1R,4S)-2-(benzyloxymethyl)-4-(4-methylsulfanylpyrrolo[2,1-f][1,2,4]triazin-7-yl)cyclopent-2-en-1-ol 
• 158227-80-6 7-((2S,3S,4R,5R)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)-tetrahydrofuran-2-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine 

Relevant articles and documents

SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES

The disclosure provides biologically active compounds of formula (I): and pharmaceutically acceptable salts thereof, compositions containing these compounds, and methods of using these compounds in a variety applications, such as treatment of diseases or disorders associated with E1 type activating enzymes, and with Nedd8 activating enzyme (NAE) in particular.